Mr.Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

 

πŸ‘¨β€πŸ« 🌾🌟Mr. Surapon Nochaiwong, a distinguished figure in pharmacoepidemiology and clinical epidemiology, serves as an academic staff member in the Department of Pharmaceutical Care at Chiang Mai University, Thailand. πŸŽ“ Holding a Doctor of Pharmacy (Pharm.D.) degree, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at the Faculty of Pharmacy.Nochaiwong’s educational journey includes a Pharm.D. from Chiang Mai University, a General Residency in Pharmacotherapy, and diplomas in Clinical Statistics and Clinical Epidemiology. His commitment to education and research makes him a respected figure in the academic and scientific community. πŸ”¬πŸŽ“

 

🌐 Professional Profiles

Affiliation/Community πŸ›οΈ

Pharmacoepidemiology and Statistics Research Center (PESRC) Faculty of Pharmacy, Chiang Mai University 50200 Department of Pharmaceutical Care Faculty of Pharmacy, Chiang Mai University 50200

Personal Statement 🌟

Surapon Nochaiwong earned his Doctor of Pharmacy (Pharm.D.) degree from Chiang Mai University, Thailand. Currently holding an academic position in the Department of Pharmaceutical Care, Faculty of Pharmacy, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at Chiang Mai University.

Since joining the Faculty of Pharmacy in 2012, Nochaiwong has actively contributed as a young scientist and principal investigator on over 10 extramurally funded local and national grants. He has an impressive publication record with more than 50 manuscripts and conference abstracts, accumulating over 800 citations in the international scientific community. His research interests span clinical epidemiology, pharmacoepidemiology, patient-reported outcomes in dialysis patients, and systematic review & evidence-based synthesis in nephrology and dermatology.

Areas of Expertise/Knowledge 🧠

Clinical Epidemiology, Pharmacoepidemiology, Dialysis, Chronic Pruritus, Patient-Reported Outcomes, Systematic Review and Knowledge Synthesis, Mental Health and COVID-19

Positions and Honors πŸ†

2021 – Present: Co-principal investigator, Government of Canada, the Canadian Institutes of Health Research (CIHR) Operating Grant: Emerging COVID-19 Research Gaps & Priorities, 2020 – Present: Principal investigator and head of the HOME-COVID-19 consortium, 2016 – Present: Head of the Pharmacoepidemiology and Statistics Research Center (PESRC), 2017 – Present: Head of the Thai Renal Outcomes Research (THOR) Investigators, 2019 – Present: Vice head of the Evidence-Based Synthesis in Dermatology (EBSD), 2015 – 2017: Co-principal investigator, Funded by Health Systems Research Institute of Thailand (HSRI) through National Research Council of Thailand (NRCT), 2013 – 2014: Principal investigator, Young Researcher Granted by Chiang Mai University

Education πŸ“š

Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Chiang Mai University, Thailand, General Residency in Pharmacotherapy, The College of Pharmacotherapy of Thailand, Thailand, Β Diploma in Clinical Statistics, Faculty of Medicine, Chiang Mai University, ThailandΒ Diploma in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Thailand

Work Experience πŸ‘¨β€πŸ’Ό

2012-Present: Faculty of Pharmacy, Chiang Mai University, Thailand This detailed information provides a comprehensive overview of Surapon Nochaiwong’s academic and research journey, along with his significant contributions and affiliations in the field of pharmacy and healthcare.

πŸ“šTop Noted Publication

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review

Psychological Resilience and Adverse Mental Health Issues in the Thai Population during the Coronavirus Disease 2019 Pandemic

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis

Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

You May Also Like